Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wisinski

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 2, 2017
Assessment of adherence and relative dose intensity with oral chemotherapy in oncology clinical trials at an academic medical centerJeff A Engle, Anne M Traynor, Toby C Campbell, et al.
Breast Cancer Research and Treatment|February 22, 2012
Aromatase inhibitors and calcium absorption in early stage breast cancerAmye Tevaarwerk, Mark E Burkard, Kari B Wisinski, et al.
Molecular Cancer Research : MCR|August 31, 2017
EPAC-RAP1 Axis-Mediated Switch in the Response of Primary and Metastatic Melanoma to Cyclic AMPCarlos I Rodríguez, Edgardo Castro-Pérez, Kirthana Prabhakar, et al.
Cancer Research|January 25, 2018
Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced ERα<sup>+</sup> Mammary CarcinomasMichael P Shea, Kathleen A O'Leary, Saja A Fakhraldeen, et al.
Investigational New Drugs|December 23, 2016
A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumorsChristos E Kyriakopoulos, Amy M Braden, Jill M Kolesar, et al.
Investigational New Drugs|November 10, 2016
Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancerMurtuza Rampurwala, Kari B Wisinski, Mark E Burkard, et al.
Scientific Reports|August 30, 2019
Effects of culture method on response to EGFR therapy in head and neck squamous cell carcinoma cellsJose M Ayuso, Ross Vitek, Adam D Swick, et al.
JAMA|October 2, 2008
Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer riskVirginia G Kaklamani, Kari B Wisinski, Maureen Sadim, et al.
Breast Cancer Research and Treatment|November 9, 2011
Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicityGabrielle Rocque, Adedayo Onitilo, Jessica Engel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2016
Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast CancerKari B Wisinski, Amye J Tevaarwerk, Mark E Burkard, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 2, 2017
Assessment of adherence and relative dose intensity with oral chemotherapy in oncology clinical trials at an academic medical centerJeff A Engle, Anne M Traynor, Toby C Campbell, et al.
Breast Cancer Research and Treatment|February 22, 2012
Aromatase inhibitors and calcium absorption in early stage breast cancerAmye Tevaarwerk, Mark E Burkard, Kari B Wisinski, et al.
Molecular Cancer Research : MCR|August 31, 2017
EPAC-RAP1 Axis-Mediated Switch in the Response of Primary and Metastatic Melanoma to Cyclic AMPCarlos I Rodríguez, Edgardo Castro-Pérez, Kirthana Prabhakar, et al.
Cancer Research|January 25, 2018
Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced ERα<sup>+</sup> Mammary CarcinomasMichael P Shea, Kathleen A O'Leary, Saja A Fakhraldeen, et al.
Investigational New Drugs|December 23, 2016
A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumorsChristos E Kyriakopoulos, Amy M Braden, Jill M Kolesar, et al.
Investigational New Drugs|November 10, 2016
Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancerMurtuza Rampurwala, Kari B Wisinski, Mark E Burkard, et al.
Scientific Reports|August 30, 2019
Effects of culture method on response to EGFR therapy in head and neck squamous cell carcinoma cellsJose M Ayuso, Ross Vitek, Adam D Swick, et al.
JAMA|October 2, 2008
Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer riskVirginia G Kaklamani, Kari B Wisinski, Maureen Sadim, et al.
Breast Cancer Research and Treatment|November 9, 2011
Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicityGabrielle Rocque, Adedayo Onitilo, Jessica Engel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2016
Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast CancerKari B Wisinski, Amye J Tevaarwerk, Mark E Burkard, et al.
Pageof 14